Sword Health
Rajeev Dham is a seasoned executive with extensive experience in investment and management. Currently serving as the Managing Director at Sapphire since July 2013, Rajeev holds investor positions at multiple companies, including Glean, Supio, Constructor, Creatio, Verse, BioCatch, Qualified, CaptivateIQ, and Paper, with most roles beginning between 2022 and 2024. Rajeev Dham obtained a Bachelor of Science in Business Administration from the USC Marshall School of Business and an MBA from Harvard Business School, alongside early education at Mission San Jose High School.
This person is not in any teams
This person is not in any offices
Sword Health
18 followers
Sword Health is on a mission to free 2 billion people from pain by pioneering the field of AI Care. Sword has developed the first platform to predict, prevent, and treat pain by starting with the expertise of world-class doctors of physical therapy and then building an interactive AI experience to deliver care that members can use anywhere, anytime, under a clinician’s supervision. Delivering over 1.5 million AI sessions to members in 2023 and available to over 10,000 employers across three continents, Sword holds the majority of industry patents, a 70% win rate in competitive evaluations, and has raised over $300 million in funding from major venture firms, including Founders Fund, General Catalyst, and Khosla Ventures. Recently ranked the 26th fastest-growing US company on the Inc. 5000 list, Sword is redefining healthcare by saving clients millions while delivering unparalleled recovery from pain to its members.